Product Description
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Unknown
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Seren Pharmaceuticals Inc.
Company Location: Western America
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: Japan
Active Clinical Trial Count: 2
Recent & Upcoming Milestones
Highest Development Phases
Phase 1: Candidiasis|Healthy Volunteers
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
jRCT2071240129 |
jRCT2071240129 | P1 |
Not yet recruiting |
Candidiasis |
2025-09-30 |
|||
jRCT2071230046 |
jRCT2071230046 | P1 |
Not yet recruiting |
Healthy Volunteers |
1970-01-01 |
Recent News Events
Date |
Type |
Title |
|---|